In recent years, it has become increasingly clear that many drugs on the market or in development are simply not optimized for clinical use. For example, conventional oral drug administration usually does not offer control over the rate of drug release or the ability to target specific tissues in the body. Meanwhile, about half of existing drugs and most of newly identified small molecules are insoluble, and therefore are not effectively absorbed into the bloodstream. Due to these limitations, high doses are often required to achieve the desired therapeutic effect, increasing the risk of adverse outcomes in patients.
To address these problems, Phosphorex is harnessing the potential of polymer microspheres and nanoparticles for enhanced drug delivery and has developed a full range of drug delivery solutions that can be customized for a variety of applications.
Leveraging our experience and proprietary technologies, we encapsulate drugs into microspheres or nanoparticles to enable sustained release, protection of therapeutic agents from degradation, as well as targeted drug delivery. Moreover, we have pioneered state-of-the-art techniques to improve the solubility of both new and existing drugs.
At Phosphorex, we work closely with customers and collaborators to find the drug delivery solution that best fits their needs and our experts support clients though all stages of the development process, from formulation development to clinical trials.
We are excited about partnering with our customers in the development and growth of new cutting-edge applications. Through these partnerships, we look forward to further using our capabilities and expertise to propel research and development programs forward and optimize the clinical results of both new and existing drugs.